-
Chinese medical journal · Apr 2023
Outcome comparison of pyrotinib with current standard of care in the second/third line setting in advanced non-small cell lung cancer patients with HER2 mutation.
- Shiqi Mao, Libo Luo, Shuo Yang, Yan Wang, Fei Zhou, Jia Yu, Bin Chen, Guanghui Gao, Xuefei Li, Chao Zhao, Lei Cheng, Yiwei Liu, Wanying Wang, Keyi Jia, Chuchu Shao, Xinyu Liu, Xiaoxia Chen, Chunxia Su, Caicun Zhou, Fengying Wu, and Shengxiang Ren.
- Department of Medical Oncology, Shanghai Pulmonary Hospital, Cancer Institute, Tongji University School of Medicine, Shanghai 200433, China.
- Chin. Med. J. 2023 Apr 5; 136 (7): 848850848-850.
no abstract available
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.